"10.1371_journal.ppat.1002510","plos pathogens","2012-02-09T00:00:00Z","Lisa Marcinowski; Mélanie Tanguy; Astrid Krmpotic; Bernd Rädle; Vanda J Lisnić; Lee Tuddenham; Béatrice Chane-Woon-Ming; Zsolt Ruzsics; Florian Erhard; Corinna Benkartek; Marina Babic; Ralf Zimmer; Joanne Trgovcich; Ulrich H Koszinowski; Stipan Jonjic; Sébastien Pfeffer; Lars Dölken","Max von Pettenkofer-Institute, Ludwig-Maximilians-University Munich, Munich, Germany; Architecture et Réactivité de l'ARN, Université de Strasbourg, Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France; Department of Histology and Embryology, Faculty of Medicine University of Rijeka, Rijeka, Croatia; Institute for Informatics, Ludwig-Maximilians-University Munich, Munich, Germany; Department of Virology, Hannover Medical School, Hannover, Germany; Department of Pathology, The Ohio State University, Columbus, Ohio, United States of America; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom","Conceived and designed the experiments: LD SP SJ. Performed the experiments: LM MT AK BR VJL LT CB MB SP LD. Analyzed the data: AK LT VJL BCWM ZR FE RZ SJ SP LD. Contributed reagents/materials/analysis tools: CB MB RZ JT UHK. Wrote the paper: LM MT LT SJ SP LD.","A patent application has been filed using the m169 transcript to target miRNAs for degradation. Besides this, there are no competing interests.","2012","02","Lisa Marcinowski","LM",17,FALSE,3,10,10,6,TRUE,FALSE,FALSE,0,NA,FALSE
